BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12351817)

  • 1. The molecular perspective: DNA topoisomerases.
    Goodsell DS
    Stem Cells; 2002; 20(5):470-1. PubMed ID: 12351817
    [No Abstract]   [Full Text] [Related]  

  • 2. [DNA-topoisomerases and their functions in cell].
    Giliarov DA; Shkundina IS
    Mol Biol (Mosk); 2012; 46(1):52-63. PubMed ID: 22642101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Arylamino-7-chloro-quinazoline-5,8-diones as novel cytotoxic and DNA topoisomerase inhibitory agents.
    Park HJ; Kim YS; Kim JS; Lee EJ; Yi YJ; Hwang HJ; Suh ME; Ryu CK; Lee SK
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3385-8. PubMed ID: 15177438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of novel 6-chloro-/fluorochromone derivatives as potential topoisomerase inhibitor anticancer agents.
    Ishar MP; Singh G; Singh S; Sreenivasan KK; Singh G
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1366-70. PubMed ID: 16332438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nuclear dynamics during the cell cycle: overview].
    Kimura H
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2115-6. PubMed ID: 17471920
    [No Abstract]   [Full Text] [Related]  

  • 6. Disentangling DNA during replication: a tale of two strands.
    Hardy CD; Crisona NJ; Stone MD; Cozzarelli NR
    Philos Trans R Soc Lond B Biol Sci; 2004 Jan; 359(1441):39-47. PubMed ID: 15065655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RecQ helicases and topoisomerases: implications for genome stability in humans.
    Franchitto A
    Ital J Biochem; 2007 Jun; 56(2):115-21. PubMed ID: 17722652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
    Das A; Dasgupta A; Sengupta T; Majumder HK
    Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of new oligopyrrole carboxamides linked with tricyclic DNA-intercalators as potential DNA ligands or topoisomerase inhibitors.
    David-Cordonnier MH; Hildebrand MP; Baldeyrou B; Lansiaux A; Keuser C; Benzschawel K; Lemster T; Pindur U
    Eur J Med Chem; 2007 Jun; 42(6):752-71. PubMed ID: 17433851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Menthol inhibits DNA topoisomerases I, II alpha and beta and promotes NF-kappaB expression in human gastric cancer SNU-5 cells.
    Lin JP; Lu HF; Lee JH; Lin JG; Hsia TC; Wu LT; Chung JG
    Anticancer Res; 2005; 25(3B):2069-74. PubMed ID: 16158947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA topoisomerases in cancer chemotherapy: using enzymes to generate selective DNA damage.
    Nitiss JL
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1512-6. PubMed ID: 12431029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of conjugated eicosapentaenoic acid on mammalian DNA polymerase and topoisomerase activities and human cancer cell proliferation.
    Yonezawa Y; Hada T; Uryu K; Tsuzuki T; Eitsuka T; Miyazawa T; Murakami-Nakai C; Yoshida H; Mizushina Y
    Biochem Pharmacol; 2005 Aug; 70(3):453-60. PubMed ID: 15963470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reverse gyrase: an insight into the role of DNA-topoisomerases.
    Nadal M
    Biochimie; 2007 Apr; 89(4):447-55. PubMed ID: 17316953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerases and the regulation of neural function.
    McKinnon PJ
    Nat Rev Neurosci; 2016 Nov; 17(11):673-679. PubMed ID: 27630045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of topoisomerases as anticancer drugs: problems and prospects.
    Dwarakanath BS; Khaitan D; Mathur R
    Indian J Exp Biol; 2004 Jul; 42(7):649-59. PubMed ID: 15339028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New carbocyclic analogues of netropsin: synthesis and inhibition of topoisomerases.
    Pućkowska A; Bielawski K; Bielawska A; Rózański A
    Acta Biochim Pol; 2002; 49(1):177-83. PubMed ID: 12136938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.
    Montagnoli A; Valsasina B; Croci V; Menichincheri M; Rainoldi S; Marchesi V; Tibolla M; Tenca P; Brotherton D; Albanese C; Patton V; Alzani R; Ciavolella A; Sola F; Molinari A; Volpi D; Avanzi N; Fiorentini F; Cattoni M; Healy S; Ballinari D; Pesenti E; Isacchi A; Moll J; Bensimon A; Vanotti E; Santocanale C
    Nat Chem Biol; 2008 Jun; 4(6):357-65. PubMed ID: 18469809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of substituted naphthalene imides and diimides as anticancer agent.
    Tumiatti V; Milelli A; Minarini A; Micco M; Gasperi Campani A; Roncuzzi L; Baiocchi D; Marinello J; Capranico G; Zini M; Stefanelli C; Melchiorre C
    J Med Chem; 2009 Dec; 52(23):7873-7. PubMed ID: 19954251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.
    Cho WJ; Le QM; My Van HT; Youl Lee K; Kang BY; Lee ES; Lee SK; Kwon Y
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3531-4. PubMed ID: 17498951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerases mutations and fluoroquinolone resistance in Stenotrophomonas maltophilia.
    Trigo Daporta M; Muñoz Bellido JL; García-Rodríguez JA
    Int J Antimicrob Agents; 2004 Nov; 24(5):520-1. PubMed ID: 15519490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.